chuminhua2019-01-03 23:08
$Ohr制药(OHRP)$
12/3,NeuBase Therapeutics通过反向收购Ohr Pharmaceutical,在纳斯达克上市。NeuBase的模块化反义肽核酸(PNA)平台PATrOL用于改善基因沉默疗法。网页链接查看全文
$Ohr制药(OHRP)$ 425 - Prospectuses and communications, business combinations Filed: 2019-07-11 AccNo: 0001387131-19-004993 Size: 59 KB 网页链接
$Ohr制药(OHRP)$ 8-K/A [Amend] - Current report Filed: 2019-07-11 AccNo: 0001387131-19-004992 Size: 58 KBItem 5.07: Submission of Matters to a Vote of Security HoldersItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Ohr制药(OHRP)$ 425 - Prospectuses and communications, business combinations Filed: 2019-07-10 AccNo: 0001387131-19-004961 Size: 77 KB 网页链接
$Ohr制药(OHRP)$ 8-K - Current report Filed: 2019-07-10 AccNo: 0001387131-19-004960 Size: 76 KBItem 5.07: Submission of Matters to a Vote of Security HoldersItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Ohr制药(OHRP)$ 425 - Prospectuses and communications, business combinations Filed: 2019-07-08 AccNo: 0001387131-19-004892 Size: 60 KB 网页链接
$Ohr制药(OHRP)$ 425 - Prospectuses and communications, business combinations Filed: 2019-07-03 AccNo: 0001387131-19-004833 Size: 98 KB 网页链接
$Ohr制药(OHRP)$ 8-K - Current report Filed: 2019-07-03 AccNo: 0001387131-19-004832 Size: 97 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Ohr制药(OHRP)$ 425 - Prospectuses and communications, business combinations Filed: 2019-07-02 AccNo: 0001387131-19-004795 Size: 59 KB 网页链接
$Ohr制药(OHRP)$ EFFECT - Notice of Effectiveness Filed: 2019-06-06 AccNo: 9999999995-19-001291 Size: 1 KB 网页链接
$Ohr制药(OHRP)$ CT ORDER - Confidential treatment order Filed: 2019-06-07 AccNo: 9999999997-19-005367 Size: 92 KB 网页链接